| 1 Komoike Y,Akiyama F,Iino Y.Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors[J].Breast Cancer,2005,12(2):104-111.
2沈镇宙,邵志敏.现代乳腺肿瘤学进展[M].上海:上海科学技术文献出版社,2002.209-225.
3王晓东.乳腺癌局部复发的综合治疗[J].基层医学论坛,2007,11,(4):355- 356.
4赵勇,文浩.乳腺癌根治术后单纯局部复发的治疗[J].国外医学肿瘤学分册,1999,26(1):42-44.
5 Osborne MP,Borgen P I,Wong GY,et al.Salvage mastectomy for local and regional recurrence after breast conserving operation and radiation therapy[J].Surg Gynecol Obstet,1992,174(3):189-194.
6 Solin LJ,Fourquet A,McCormick B,et al.Salvage treatment for local recurrence following breast conserving surgery and definitive irradiation for ductal carcinoma in-situ(intraductal carcinoma) of the breast[J].Int J Radial Oncol Biol Phys, 1994,30(1):329.
7卢崇亮.转移性乳腺癌的治疗进展[J].中国现代普通外科进展,2006,9 (1):10-13.
8于志勇,左文述,魏玲,等.阿霉素对不同乳腺癌细胞株的抑制及凋亡调控作用[J].中华医学杂志,2005,85(1):19-22.
9 Blum JL,Dieras V,Lo Russo PM,et al.Multicancer phaseⅡstudy of capecitabine in taxane-pretreated metastatic breast carcinoma patients[J].Cancer,2001, 92:1759-68.
10 Fumoleau P,Largillier R,Trillet-Lenoir V,et al.Phase H study of capecitabine (Xeloda) in pts with advanced breast cancer(ABC),previously treated with anthracyclines and taxanes[J].Breast Cancer Res Treat,2001,69:285a.
11 Biganzoli L,Minisini A,Aapro M,et aL Chemotherapy for metastatic breast cancer [J],Curropin Obstet Gynecol,2004,16:37-41.
12江泽飞,姚开泰,宋三泰.乳腺癌治疗的新循证医学证据[J].中华医学杂志,2005,85:3025-27.
13田嘉玲,宫超,黄克楠,等.诺维本联合化疗治疗晚期复发乳腺癌10例临床观察[J].中国肿瘤临床,2001,28(4):311-312.
14 Marwane G,Fadi F,Joseph K,et al.诺维本与希罗达联合应用作为一线治疗方案在转移性乳腺癌中的作用[J].ASCO,2002,N19781.
15汪勇,蔡秀军.乳腺癌术后局部复发的危险因素及预后分析[J].中国医师杂志,2003,5(7):933-935.
16唐鲁兵.乳腺癌术后局部复发的因素及治疗[J].医师进修杂志(外科版), 2004,27(6):57-59.
17王华庆,钱正子.乳腺癌的内分泌治疗[J].中国实用内科杂志,2007,27 (24):1911-13.
18王甜甜.乳腺癌内分泌治疗研究现状[J].中国现代普通外科进展,2004,7 (5):260-262.
19戚晓军,赵卫红,王怀瑾,等.乳腺癌的分子靶向治疗研究进展[J].中国处方药,2008,4(73):82-87
20任军.乳腺癌的分子靶向治疗[J].中国实用内科杂志,2007,27(24): 1907-10. |
